News

When Debbie O’Neal was diagnosed with heart failure at 75, she feared her life was ending. She was the same age that her mother had been when she died of heart disease.

This week we're talking with Dr. Sanjaya Gupta, cardiologist at Saint Luke’s Mid America Heart Institute, about the latest treatment options for this underdiagnosed heart condition.

The Wall Street Journal invited Dr. James O’Keefe, MD, director of preventive cardiology at Saint Luke’s Mid America Heart Institute, to explain the potential risk and share tips on how you can protect your heart during the big game.

Dr. Sanjaya Gupta spoke to KSHB about pulsed field ablation, as well as the second Saint Luke's patient to undergo this innovative new procedure to treat AFib.

Dr. Tracy Stevens and Dr. Anna Grodzinsky joined the America's Healthcare Advocate podcast to talk about heart conditions in women.

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.

MedCity News talked to Dr. Sanjaya Gupta, cardiologist at Saint Luke's Mid America Heart Institue, about how the new virtual program to help patients with atrial fibrillation came to be.

The new, co-developed a-fib program delivers holistic care that magnifies specialty providers’ ability to see more patients and improve their quality of life.

During Heart Month, we are talking about atrial fibrillation, the recent changes in guidelines, and how Saint Luke’s is leading the way in innovative treatments for those who have a-fib.

Saint Luke’s Mid America Heart Institute was the first in Kansas and Missouri, and one of only 27 US institutions, to participate in PULSED AF clinical trial.